XML 51 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Measurements  
Schedule of fair value on a recurring basis

Nine months ended

September 30, 2024

Fair Value

Level 1

Level 2

Level 3

Total

Derivative liability - Equity Investment Right

$

1,311

$

$

$

1,311

$

1,311

Derivative liability - OnkosXcel Warrants

121

121

121

Derivative liability - BTI Warrants

2,935

2,935

2,935

Total derivative liabilities

$

4,367

$

$

2,935

$

1,432

$

4,367

Schedule of changes in Level 2 and Level 3 liabilities

Nine months ended

September 30, 

2024

2023

Derivative liabilities, Balance - January 1

$

1,905

$

2,343

Change in fair value

(473)

(316)

Derivative liabilities, Balance - September 30

$

1,432

$

2,027

Schedule of fair value unobservable inputs

Equity Investment Right

Strike price relative to volume weighted 30-day average

110.0

%

Volatility (annual)

112.3

%

Probability of exercise

91.0

%

Time period

1.4

years

Estimated premium to 30-day average

25.0

%

Discount rate

3.9

%